Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Asset disposition
Appointed director
CTI BIOPHARMA CORP (CTI) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/06/2023 8-K Quarterly results
Docs: "CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results – Growing physician awareness and usage of VONJO® drove quarterly double-digit revenue growth –"
11/07/2022 8-K Quarterly results
Docs: "CTI BioPharma Reports Third Quarter 2022 Financial Results – VONJO® net product revenue of $18.2 million in the third quarter, a 48% increase compared to the second quarter –"
08/08/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: "CTI BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results – VONJOTM Approved by FDA for the Treatment of Adult Myelofibrosis Patients with Myelofibrosis and Thrombocytopenia&#59; Commercial Launch Underway –"
08/05/2021 8-K Quarterly results
03/17/2021 8-K Quarterly results
11/10/2020 8-K Quarterly results
Docs: "CTI BioPharma Reports Third Quarter 2020 Financial Results – Rolling NDA Submission for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia Initiated in October –"
08/06/2020 8-K Quarterly results
05/07/2020 8-K Quarterly results
03/12/2020 8-K Quarterly results
11/04/2019 8-K Quarterly results
Docs: "CTI BioPharma Reports Third Quarter 2019 Financial Results"
08/01/2019 8-K Quarterly results
Docs: "CTI BioPharma Reports Second Quarter 2019 Financial Results"
05/02/2019 8-K Quarterly results
Docs: "CTI BioPharma Reports First Quarter 2019 Financial Results"
03/13/2019 8-K Quarterly results
Docs: "CTI BioPharma Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights"
11/01/2018 8-K Quarterly results
Docs: "CTI BioPharma Reports Third Quarter 2018 Financial Results -Management to Host Conference Call/ Webcast Today at 4:30 p.m. Eastern Time-"
08/02/2018 8-K Quarterly results
Docs: "CTI BioPharma Reports Second Quarter 2018 Financial Results -Management to Host Conference Call/ Webcast Today at 4:30 p.m. Eastern Time-"
05/03/2018 8-K Quarterly results
Docs: "CTI BioPharma Reports First Quarter 2018 Financial Results -Management to Host Conference Call/ Webcast Today at 4:30 p.m. Eastern Time-"
03/07/2018 8-K Quarterly results
Docs: "CTI BioPharma Reports Fourth Quarter and Full Year 2017 Financial Results -Management to Host Conference Call/ Webcast Today at 4:30 p.m. Eastern Time-"
08/03/2017 8-K Quarterly results
Docs: "CTI BioPharma Reports Second Quarter 2017 Financial Results -PAC203 Phase 2 Trial of Pacritinib Initiated -Marketing Authorization Application for Pacritinib Under Review by European Medicines Agency -Enrollment Completed in the PIX306 Phase 3 Trial of PIXUVRI ® -Management to Host Conference Call/ Webcast Today at 4:30 p.m. Eastern time"
08/03/2017 8-K Quarterly results
Docs: "CTI BioPharma Reports Second Quarter 2017 Financial Results -PAC203 Phase 2 Trial of Pacritinib Initiated -Marketing Authorization Application for Pacritinib Under Review by European Medicines Agency -Enrollment Completed in the PIX306 Phase 3 Trial of PIXUVRI ® -Management to Host Conference Call/ Webcast Today at 4:30 p.m. Eastern time SEATTLE, WA, August 3, 2017 - CTI BioPharma Corp. today reported financial results for the second quarter ended June 30, 2017. Recent Highlights Clinical / Regulatory"
05/03/2017 8-K Form 8-K - Current report
05/03/2017 8-K Form 8-K - Current report
03/02/2017 8-K Form 8-K - Current report
03/02/2017 8-K Form 8-K - Current report
11/08/2016 8-K Quarterly results
Docs: "CTI BIOPHARMA REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS"
11/08/2016 8-K Quarterly results
Docs: "CTI BIOPHARMA REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS"
08/04/2016 8-K Quarterly results
Docs: "CTI BIOPHARMA REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS"
08/04/2016 8-K Form 8-K - Current report
05/10/2016 8-K Form 8-K - Current report
05/10/2016 8-K Quarterly results
Docs: "CTI BIOPHARMA REPORTS FIRST QUARTER 2016 FINANCIAL RESULTS"
02/16/2016 8-K Form 8-K - Current report
02/16/2016 8-K Quarterly results
Docs: "CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2015 FINANCIAL RESULTS"
11/05/2015 8-K Quarterly results
Docs: "CTI BIOPHARMA REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy